Guangdong OptoMedic Technologies Inc. – Trademark Portfolio

Entity Type: 99

Guangdong OptoMedic Technologies Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include FLONAVI and OPTOMEDIC.

Suite 503, Building A,

Golden Valley Intellicreation Community,No.2 Yonganbei Street, Daxu, Guicheng, Nanhai, Foshan 528200 Guangdong

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OPTOMEDIC
OPTOMEDIC
Registered 2021
FLONAVI
FLONAVI
Registered 2021

Trademark Classifications

Guangdong OptoMedic Technologies Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Guangdong OptoMedic Technologies Inc. have?

Guangdong OptoMedic Technologies Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Guangdong OptoMedic Technologies Inc. file in?

Guangdong OptoMedic Technologies Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Guangdong OptoMedic Technologies Inc.'s most well-known trademarks?

Guangdong OptoMedic Technologies Inc.'s registered trademark portfolio includes well-known marks such as FLONAVI and OPTOMEDIC. These are among 2 currently registered trademarks in the portfolio.

What is Guangdong OptoMedic Technologies Inc.'s trademark registration success rate?

Guangdong OptoMedic Technologies Inc. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.